Dashboard
Manage Tickers

STIMNeuronetics, Inc.

Nasdaq neurostar.com


$ 0.78 $ 0.05 (6.7 %)    

Monday, 16-Sep-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 0.78
$ 0.78 x 400
-- x --
-- - --
$ 0.66 - $ 5.07
797,535
na
23.63M
$ 1.89
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 03-08-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-07-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-02-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-08-2022 12-31-2021 10-K
12 11-09-2021 09-30-2021 10-Q
13 08-03-2021 06-30-2021 10-Q
14 05-04-2021 03-31-2021 10-Q
15 03-02-2021 12-31-2020 10-K
16 11-02-2020 09-30-2020 10-Q
17 08-04-2020 06-30-2020 10-Q
18 05-05-2020 03-31-2020 10-Q
19 03-03-2020 12-31-2019 10-K
20 11-05-2019 09-30-2019 10-Q
21 08-06-2019 06-30-2019 10-Q
22 05-07-2019 03-31-2019 10-Q
23 03-05-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

neurostar-releases-software-upgrades-neurostar-advanced-therapy-and-proprietary-trakstar-patient-data-management-software
NeuroStar Releases Software Upgrades Neuro...
09/16/2024 12:33:48

retractable-technologies-and-2-other-penny-stocks-executives-are-buying
Retractable Technologies And 2 Other Penny...
09/09/2024 13:13:05

butterfly-network-and-3-other-stocks-under-2-executives-are-aggressively-buying
Butterfly Network And 3 Other Stocks Under...
09/03/2024 10:54:58

jmp-securities-maintains-market-outperform-on-neuronetics-lowers-price-target-to-3
JMP Securities Maintains Market Outperform...
08/14/2024 18:00:20

JMP Securities analyst David Turkaly maintains Neuronetics (NASDAQ:STIM) with a Market Outperform and lowers the price targe...

canaccord-genuity-maintains-buy-on-neuronetics-lowers-price-target-to-3
Canaccord Genuity Maintains Buy on Neurone...
08/13/2024 12:05:39

Canaccord Genuity analyst William Plovanic maintains Neuronetics (NASDAQ:STIM) with a Buy and lowers the price target from $...

william-blair-downgrades-neuronetics-to-market-perform
William Blair Downgrades Neuronetics to Ma...
08/12/2024 22:23:41

William Blair analyst Margaret Kaczor downgrades Neuronetics (NASDAQ:STIM) from Outperform to Market Perform.

gold-gains-over-1-starbucks-shares-move-higher
Gold Gains Over 1%; Starbucks Shares Move ...
08/12/2024 18:33:03

noninvasive-treatment-provider-neuronetics-agrees-to-merge-with-canadian-firm-greenbrook-tms-reports-q2-earnings-and-guidance-below-expectations
Noninvasive Treatment Provider Neuronetics...
08/12/2024 17:12:56

Neuronetics to acquire Greenbrook TMS (OTC: GBNHF) in an all-stock deal, doubling revenue to $145M. The combined company expect...

crude-oil-surges-2-b-riley-financial-shares-plunge
Crude Oil Surges 2%; B. Riley Financial Sh...
08/12/2024 16:00:21

dow-dips-150-points-mondaycom-posts-upbeat-earnings
Dow Dips 150 Points; Monday.com Posts Upbe...
08/12/2024 13:49:15

neuronetics-forecasts-q3-revenue-of-185m-195m-versus-consensus-of-20115m-with-2024-sales-of-78m-80m-compared-to-consensus-of-7915m
Neuronetics Forecasts Q3 revenue of $18.5M...
08/12/2024 11:18:12

For the full year 2024, the Company expects total operating expenses to be between $78.0 million and $80.0 million.

neuronetics-agreed-to-acquire-greenbrook-tms-in-an-all-stock-transaction
Neuronetics Agreed To Acquire Greenbrook T...
08/12/2024 11:15:55

The transaction creates a vertically-integrated organization capable of providing access to mental health treatment with signif...

neuronetics-q2-2024-gaap-eps-033-misses-027-estimate-sales-16450m-miss-18648m-estimate
Neuronetics Q2 2024 GAAP EPS $(0.33) Misse...
08/12/2024 11:13:27

neuronetics-announces-aetna-policy-update-expands-tms-availability-for-adolescents-with-depression
Neuronetics Announces Aetna Policy Update ...
07/22/2024 12:38:29

Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that imp...

neuronetics-announces-bcbs-of-michigan-and-cambia-health-solutions-to-broaden-access-to-neurostar-tms-for-patients-15-and-older-policy-updates-follow-fda-clearance-for-adolescents-with-mdd
Neuronetics Announces BCBS of Michigan And...
07/10/2024 12:32:51

neuronetics-and-3-other-stocks-under-3-insiders-are-buying
Neuronetics And 3 Other Stocks Under $3 In...
06/07/2024 11:48:26

Core News & Articles
Neuronetics Announced That Humana Has Beco...
05/15/2024 11:34:47

william-blair-upgrades-neuronetics-to-outperform
William Blair Upgrades Neuronetics to Outp...
05/14/2024 13:04:42

William Blair analyst Margaret Kaczor upgrades Neuronetics (NASDAQ:STIM) from Market Perform to Outperform.

nasdaq-moves-lower-great-lakes-dredge--dock-shares-surge-following-upbeat-earnings
Nasdaq Moves Lower; Great Lakes Dredge & D...
05/07/2024 18:58:50

why-beyond-shares-are-trading-lower-by-over-20-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Beyond Shares Are Trading Lower By Ove...
05/07/2024 18:35:21

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION